Literature DB >> 4790579

In vitro bactericidal effectiveness of four aminoglycoside antibiotics.

P J Hyams, M S Simberkoff, J J Rahal.   

Abstract

The antibacterial activity of four aminoglycoside antibiotics (gentamicin, Sch 13706, tobramycin, and sisomicin) was tested against eight gram-negative and three gram-positive species. A total of 323 strains were studied by the broth dilution technique. Tobramycin and sisomicin had greater bacteriostatic and bactericidal activity against Pseudomonas strains than did gentamicin and Sch 13706. Of the four antibiotics, sisomicin was most active against Klebsiella, Enterobacter, Escherichia coli, indole-negative and -positive Proteus, and Streptococcus pyogenes. Gentamicin was most effective against Serratia. A fourfold or greater difference existed frequently between the minimal inhibitory and bactericidal concentrations of all antibiotics against Enterobacter and Serratia. This difference was greatest with tobramycin. Staphylococcus aureus was highly susceptible, Providencia relatively resistant, and enterococcus uniformly resistant to the antibiotics studied. Agar diffusion susceptibility testing with gentamicin and tobramycin showed that organisms susceptible to less than 6.2 mug/ml usually yielded zones 17 to 26 mm in diameters. Zones of 15 to 16 mm represented intermediate susceptibility which varied with the organism and antibiotic. Several Serratia strains required 6.2 to 12.5 mug of gentamicin/ml or 25 to 50 mug of tobramycin/ml for bactericidal activity despite minimal inhibitory concentrations of 0.09 to 3.1 mug/ml and zone sizes greater than 13 and 17 mm, respectively. Studies with Enterobacter and tobramycin yielded similar results.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4790579      PMCID: PMC444365          DOI: 10.1128/AAC.3.1.87

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Biological activity of the antibiotic components of the gentamicin complex.

Authors:  M J Weinstein; G H Wagman; E M Oden; J A Marquez
Journal:  J Bacteriol       Date:  1967-09       Impact factor: 3.490

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic.

Authors:  M J Weinstein; J A Marquez; R T Testa; G H Wagman; E M Oden; J A Waitz
Journal:  J Antibiot (Tokyo)       Date:  1970-11       Impact factor: 2.649

4.  Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation.

Authors:  W E Wick; J S Welles
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

5.  Nebramycin, a new broad-spectrum antibiotic complex. I. Detection and biosynthesis.

Authors:  W M Stark; M M Hoehn; N G Knox
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

6.  Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.

Authors:  J A Waitz; E L Moss; E M Oden; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1970-11       Impact factor: 2.649

7.  Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.

Authors:  V E Del Bene; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

8.  In vitro studies of tobramycin, an aminoglycoside antibiotic.

Authors:  J Dienstag; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

9.  Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.

Authors:  R D Meyer; L S Young; D Armstrong
Journal:  Appl Microbiol       Date:  1971-12

10.  Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1972-01
  10 in total
  15 in total

1.  Antistaphylococcal activity of sisomicin and four other aminoglycosides against strains sensitive and resistant to methicillin.

Authors:  E Yourassowsky; E Schoutens; M P Vanderlinden
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.

Authors:  P J Hyams; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

3.  Antibacterial activity of netilmicin, a new aminoglycoside antibiotic, compared with that of gentamicin.

Authors:  I Phillips; A Smith; K Shannon
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  [Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].

Authors:  H Lode; B Kemmerich; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

5.  The use of tombramycin in the management of severe infections. Clinical and pharmacological data.

Authors:  D Baron; H Drugeon; F Nicolas; A Courtieu
Journal:  Eur J Intensive Care Med       Date:  1976-09

6.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

7.  [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].

Authors:  H H Schassan
Journal:  Infection       Date:  1976       Impact factor: 3.553

8.  Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.

Authors:  S Roth; K Naber; M Scheer; G Gruenwaldt; H Lange
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

9.  Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients.

Authors:  J C Pechère; M M Pechère; R Dugal
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

10.  Comparison of activity of sisomicin and gentamicin in mouse protection tests with gram-negative bacilli.

Authors:  B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.